iNova: latest news - GoINPHARMA
Monday, 10 December 2018 - 3:44

INova

Bids for Valeant’s Inova not meeting expectations

Valeant Pharmaceuticals, owner of iNova, is reportedly dissatisfied with the three bids it has so far received for its subsidiary. It is believed that offers have come in at around AUD900m (USD 686.5m), below the expected minimum of one billion…

Private equity consortium tries to acquire Valeant’s iNova

Private equities Pacific Equity Partners and The Carlyle Group are likely to create a consortium targeting the acquisition of iNova Pharmaceuticals. iNova was acquired by Valeant in 2011 for AUD6250m and could now be sold for AUD1bn, experts say. (Source:…

Investment funds target Valeant’s iNova (AUD1bn)

US investment fund KKR seems to be targeting Australia-based iNova, owned by Valeant group, The Australian Financial Review reports. KKR, indeed, is allegedly about to initiate acquiring iNova, valued at least AUD1bn. The newspaper also mentions Pacific Equity Partners and…

iNova is on sale (AUD1bn)

Australia-based pharma group iNova (Valeant) is on sale and its teaser will be circulated to prospective buyers as early as next week. iNova was acquired in 2011 for AUD625m by Valeant, which is expecting to gain AUD1bn from it. The…